blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2313376

EP2313376 - SUBSTITUTED 1-BENZYL-CINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.11.2015
Database last updated on 25.09.2024
Most recent event   Tooltip10.08.2018Lapse of the patent in a contracting state
New state(s): PT		published on 12.09.2018  [2018/37]
Applicant(s)For all designated states
SANOFI
54, rue La Boétie
75008 Paris / FR
[2014/52]
Former [2012/18]For all designated states
SANOFI
54 rue La Boétie
75008 Paris / FR
Former [2012/17]For all designated states
SANOFI
54, rue de la Boétie
75008 Paris / FR
Former [2011/30]For all designated states
SANOFI
174, Avenue de France
75013 Paris / FR
Former [2011/17]For all designated states
Sanofi-Aventis
174 Avenue de France
75013 Paris / FR
Inventor(s)01 / BARBAGALLO, Elodie
c/o sanofi-aventis
Département Brevets
174 avenue de France
F-75013 Paris / FR
02 / RINALDI-CARMONA, Murielle
c/o sanofi-aventis
Département Brevets
174 avenue de France
F-75013 Paris / FR
03 / ROUX, Pascale
c/o sanofi-aventis
Département Brevets
174 avenue de France
F-75013 Paris / FR
04 / VERNHET, Claude
c/o sanofi-aventis
Département Brevets
174 avenue de France
F-75013 Paris / FR
 [2014/52]
Former [2011/17]01 / BARBAGALLO, Elodie
c/o sanofi-aventis Département Brevets 174 avenue de France
F-75013 Paris / FR
02 / RINALDI-CARMONA, Murielle
c/o sanofi-aventis Département Brevets 174 avenue de France
F-75013 Paris / FR
03 / ROUX, Pascale
c/o sanofi-aventis Département Brevets 174 avenue de France
F-75013 Paris / FR
04 / VERNHET, Claude
c/o sanofi-aventis Département Brevets 174 avenue de France
F-75013 Paris / FR
Representative(s)Werner, Alain Henri
Sanofi
Département Brevets
54, rue La Boétie
75008 Paris / FR
[2014/52]
Former [2011/17]Werner, Alain Henri
Sanofi-Aventis Département Brevets 174, avenue de France
75013 Paris / FR
Application number, filing date09784493.009.07.2009
[2011/17]
WO2009FR51362
Priority number, dateFR2008000397411.07.2008         Original published format: FR 0803974
[2011/17]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2010004215
Date:14.01.2010
Language:FR
[2010/02]
Type: A2 Application without search report 
No.:EP2313376
Date:27.04.2011
Language:FR
The application published by WIPO in one of the EPO official languages on 14.01.2010 takes the place of the publication of the European patent application.
[2011/17]
Type: B1 Patent specification 
No.:EP2313376
Date:24.12.2014
Language:FR
[2014/52]
Search report(s)International search report - published on:EP04.03.2010
ClassificationIPC:C07D237/28, C07D405/04, C07D409/04, A61K31/502, A61P25/00, A61P35/00, C07D237/36
[2011/17]
CPC:
C07D237/28 (EP,KR,US); A61K31/502 (KR); A61P1/00 (EP);
A61P1/04 (EP); A61P1/08 (EP); A61P1/12 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/10 (EP); A61P13/12 (EP);
A61P15/08 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/06 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P27/14 (EP);
A61P29/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/12 (EP);
A61P31/18 (EP); A61P33/00 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/08 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D405/04 (EP,US); C07D409/04 (EP,US);
C07D409/06 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/17]
Extension statesAL11.02.2011
BA11.02.2011
RS11.02.2011
TitleGerman:SUBSTITUIERTE 1-BENZYLCINNOLIN-4(1H)-ON DERIVATE, ZUBEREITUNG DAVON UND THERAPEUTISCHE ANWENDUNG DAVON[2014/32]
English:SUBSTITUTED 1-BENZYL-CINNOLIN-4(1H)-ONE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF[2011/17]
French:DERIVES DE 1-BENZYL-CINNOLIN-4-(1H)-ONE SUBSTITUES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE[2011/17]
Former [2011/17]SUBSTITUIERTE 1-BENZYLCINNOLIN-4(1H)-ONDERIVATE, ZUBEREITUNG DAVON UND THERAPEUTISCHE ANWENDUNG DAVON
Entry into regional phase11.02.2011National basic fee paid 
11.02.2011Designation fee(s) paid 
11.02.2011Examination fee paid 
Examination procedure11.02.2011Examination requested  [2011/17]
17.07.2014Communication of intention to grant the patent
13.11.2014Fee for grant paid
13.11.2014Fee for publishing/printing paid
13.11.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.07.2014
Opposition(s)25.09.2015No opposition filed within time limit [2015/49]
Fees paidRenewal fee
12.07.2011Renewal fee patent year 03
13.07.2012Renewal fee patent year 04
10.07.2013Renewal fee patent year 05
14.07.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.07.2009
AT24.12.2014
BG24.12.2014
CY24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
MK24.12.2014
MT24.12.2014
NL24.12.2014
PL24.12.2014
PT24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
SM24.12.2014
TR24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
IE09.07.2015
LU09.07.2015
BE31.07.2015
CH31.07.2015
LI31.07.2015
[2018/37]
Former [2018/30]HU09.07.2009
AT24.12.2014
BG24.12.2014
CY24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
MK24.12.2014
MT24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
SM24.12.2014
TR24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
IE09.07.2015
LU09.07.2015
BE31.07.2015
CH31.07.2015
LI31.07.2015
Former [2017/38]HU09.07.2009
AT24.12.2014
BG24.12.2014
CY24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
MT24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
SM24.12.2014
TR24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
IE09.07.2015
LU09.07.2015
BE31.07.2015
CH31.07.2015
LI31.07.2015
Former [2017/21]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
MT24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
IE09.07.2015
LU09.07.2015
CH31.07.2015
LI31.07.2015
Former [2016/33]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
IE09.07.2015
LU09.07.2015
CH31.07.2015
LI31.07.2015
Former [2016/22]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
LU09.07.2015
CH31.07.2015
LI31.07.2015
Former [2016/15]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
LU09.07.2015
Former [2016/13]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
MC24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
Former [2016/12]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SI24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
Former [2016/03]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
IT24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
Former [2015/50]AT24.12.2014
CZ24.12.2014
DK24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
Former [2015/38]AT24.12.2014
CZ24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
IS24.04.2015
Former [2015/37]CZ24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
PL24.12.2014
RO24.12.2014
SE24.12.2014
SK24.12.2014
NO24.03.2015
GR25.03.2015
Former [2015/36]CZ24.12.2014
EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
RO24.12.2014
SE24.12.2014
NO24.03.2015
GR25.03.2015
Former [2015/35]EE24.12.2014
ES24.12.2014
FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
SE24.12.2014
NO24.03.2015
GR25.03.2015
Former [2015/33]ES24.12.2014
FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
SE24.12.2014
NO24.03.2015
GR25.03.2015
Former [2015/29]FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
NL24.12.2014
SE24.12.2014
NO24.03.2015
GR25.03.2015
Former [2015/24]FI24.12.2014
HR24.12.2014
LT24.12.2014
LV24.12.2014
SE24.12.2014
NO24.03.2015
GR25.03.2015
Former [2015/23]FI24.12.2014
LT24.12.2014
NO24.03.2015
Former [2015/21]LT24.12.2014
NO24.03.2015
Former [2015/20]LT24.12.2014
Cited inInternational search[AD]WO0242269  (SANOFI SYNTHELABO [FR], et al) [AD] 1-9* the whole document *;
 [AD]  - E. STERN ET AL., "Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.", JOURNAL OF MEDICINAL CHEMISTRY, (2007), vol. 50, pages 5471 - 5484, XP002515712 [AD] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1021/JM070387H
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.